Download PDF
Thromb Haemost 1992; 68(03): 238-244
DOI: 10.1055/s-0038-1656356
Original Article
Schattauer GmbH Stuttgart

Apparent Lack of Synergism between Heparin and Dihydroergotamine in Prevention of Deep Vein Thrombosis after Elective Hip Replacement: a Randomised Double-Blind Trial Reported in Conjunction with an Overview of Previous Results

Alexander S Gallus
1   The Flinders Medical Centre, Adelaide, Australia
,
John F Cade
The Epworth Hospital, Melbourne, Australia
,
K W Mills
The Epworth Hospital, Melbourne, Australia
,
Wendy Murphy
1   The Flinders Medical Centre, Adelaide, Australia
› Author Affiliations
Further Information

Publication History

Received 04 November 1991

Accepted after revision 30 March 1992

Publication Date:
04 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

We report the results of a double-blind, randomised trial of venous thrombosis (VT) prevention in 117 patients having elective hip replacement where low dose heparin alone (5,000 IU sodium heparin given subcutaneously [sc] 8 hourly until the seventh postoperative day) was compared with low dose heparin plus dihydroergotamine (DHE; 0.5 mg, given 8 hourly by sc injection). The trial end point consisted of VT discovered through bilateral ascending venography done routinely on the seventh postoperative day. VT developed in 34% of patients given heparin/DHE (95% confidence interval = 22% – 47%) compared with 24% in those given low dose heparin alone (95% confidence interval = 14% – 37%; p = 0.34), difference = 10% (95% confidence interval = –7% to +26%). Corresponding figures for the incidence of proximal (above-knee) thrombosis were 17% and 14% (95% confidence intervals = 8% – 29% and 6% – 25% respectively). These results are discussed in the context of a detailed overview of published evidence concerning VT prevention with heparin/DHE after hip replacement and we conclude it is unlikely that heparin/DHE is markedly superior to low dose heparin alone in this clinical setting.

 

  • References

  • 1 Sheppeard H, Henson J, Ward DJ, O’Connor BT. A clinicopathological study of fatal pulmonary embolism in a specialist orthopaedic hospital. Arch Orthop Trauma Surg 1981; 99: 65-71
    CrossrefPubMedGoogle Scholar
  • 2 Gent M, Roberts RS. A meta-analysis of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest 1986; 89 (Suppl) 396S-400S
    CrossrefPubMedGoogle Scholar
  • 3 Gallus AS. Anticoagulants in prevention of venous thromboembolism. In: Antithrombotic Therapy. Hirsh J. (ed) Bailliere’s Clin Haematol: 1990. 3 651-684
    Google Scholar
  • 4 Lindblad B. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review. Acta Chir Scand 1988; Suppl 543 31-42
    PubMedGoogle Scholar
  • 5 O’Meara PM, Kaufman EE. Prophylaxis for venous thromboembolism in total hip arthroplasty: A review. Orthopedics 1990; 13: 173-178
    PubMedGoogle Scholar
  • 6 Paiement GD, Wessinger SJ, Waltman AC, Harris WH. Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients. Impedance plethysmography and fibrinogen scanning versus roentgenographic phlebography. Am J Surg 1988; 155: 400-404
    CrossrefPubMedGoogle Scholar
  • 7 Cruikshank MK, Levine MN, Hirsh J, Turpie AGG, Powers P, Jay R, Gent M. An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgery. Thromb Haemostas 1989; 62: 830-834
    PubMedGoogle Scholar
  • 8 Dahl OE, Leistad E, Nyhus S, Havig O. 99mTc-plasmin uptake test is unreliable for diagnosing asymptomatic deep vein thrombosis after hip replacement surgery. Thromb Res 1991; 62: 781-784
    CrossrefPubMedGoogle Scholar
  • 9 Seifert KB, Blackshear WM, Cruse CW, Schwarttz JA, Suslaviitch F. Bilateral upper extremity ischemia after administration of dihydroergotamine-heparin for prophylaxis of deep venous thrombosis. J Vasc Surg 1988; 8: 410-414
    CrossrefPubMedGoogle Scholar
  • 10 Ashenburg RJ, Phillips DA. Ergotism as a consequence of thromboembolic prophylaxis. Radiology 1989; 170: 375-376
    CrossrefPubMedGoogle Scholar
  • 11 Gatterer R, Wruhs O, Havelec L, Polterauer P, Marosi L. Thromboembolieprophylaxe in der Unfallchirurgie – angiospastische Komplikationen bei DHE-Heparin. Unfallchirurgie 1987; 13: 263-270
    CrossrefPubMedGoogle Scholar
  • 12 Bergqvist D. Prevention of postoperative thromboembolism in Sweden – the development of practice during five years. Thromb Haemostas 1985; 53: 239-241
    PubMedGoogle Scholar
  • 13 Rasmussen MS, Lausen I, Wille-Jorgensen P, Jorgensen T, Hauch O. Development of practice in surgical thromboprophylaxis during 10 years. Thromb Haemostas 1991; 65: 1130
    PubMedGoogle Scholar
  • 14 Emory CE, Cuddy PG. Should dihydroergotamine-heparin be used for prevention of postoperative thromboembolism?. Drug Intelligence Clin Pharmacy 1987; 21: 427-431
    PubMedGoogle Scholar
  • 15 Gallus A, Raman K, Darby T. Venous thrombosis after elective hip replacement – the influence of preventive intermittent calf compression and of surgical technique. Br J Surg 1983; 70: 17-19
    CrossrefPubMedGoogle Scholar
  • 16 Armitage P, Berry G. Statistical Methods in Medical Research (2nd Edition). Blackwell Scientific Publications; Oxford: 1987: 458-465
    Google Scholar
  • 17 Rohlf FJ, Sokal RR. Statistical Tables (2nd Ed). WH Freeman and Company; San Francisco, CA: 1981: 156-162
    Google Scholar
  • 18 Kakkar VV, Stamatakis JD, Bentley PG, Lawrence D, de Haas HA, Ward VP. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine. J Am Med Assoc 1979; 241: 39-42
    PubMedGoogle Scholar
  • 19 Tscherne H, Westermann K, Trentz O, Pretschner P, Mellmann J. Thromboembolische Komplikationen und ihre Prophylaxe beim Hüftgelenksersatz. Unfallheilkunde 1978; 81: 178-187
    PubMedGoogle Scholar
  • 20 Schondorf TH, Weber U. Prevention of deep vein thrombosis in orthopedic surgery with the combination of low dose heparin plus either dihydroergotamine or dextran. Scand J Haematol 1980; 36 (Suppl) S126-S140
    PubMedGoogle Scholar
  • 21 Liedloff H, Brauckhoff K-F, Heerdegen R, Barthel W. Zur Anwendung von Heparin in Kombination mit Dihydroergotamin zur postoperativen Thromboseprophylaxe bei Hüftgelenkoperationen. Z Gesamte Inn Med 1984; 39: 428-431
    PubMedGoogle Scholar
  • 22 Westermann K, Trentz O, Pretschner P, Mellmann J. Thromboembolism after hip surgery. Int Orthop 1981; 4: 253-257
    PubMedGoogle Scholar
  • 23 Beisaw NE, Comerota AJ, Groth HE, Merli GJ, Weitz HH, Zimmerman RC, Diserio FJ, Sasahara AA. Dihydroergotamine/Heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. J Bone Jt Surg 1988; 70-A: 02-10
    PubMedGoogle Scholar
  • 24 Sagar S, Nairn D, Stamatakis JD, Maffei FH, Higgins AF, Thomas DP, Kakkar VV. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet 1976; 1: 1151-1154
    PubMedGoogle Scholar
  • 25 Morris WT, Hardy AE. The effect of dihydroergotamine and heparin on the incidence of thromboembolic complications following total hip replacement: a randomized controlled clinical trial. Br J Surg 1981; 68: 301-303
    CrossrefPubMedGoogle Scholar
  • 26 Alfaro MJ, Paramo JA, Rocha E. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine. Thromb Haemostas 1986; 56: 53-56
    PubMedGoogle Scholar
  • 27 Fredin H, Gustafson C, Rosberg B. Hypotensive anesthesia, thromboprophylaxis and postoperative thromboembolism in total hip arthroplasty. Acta Anaesthes Scand 1984; 28: 503-507
    PubMedGoogle Scholar
  • 28 Fredin HO, Rosberg B, Arborelius M, Nylander G. On thromboembolism after total hip replacement in epidural analgesia: a controlled study of dextran 70 and low dose heparin combined with dihydroergotamine. Br J Surg 1984; 71: 58-60
    CrossrefPubMedGoogle Scholar
  • 29 Leyvraz P, Bachmann F, Vuilleumier B, Berthet S, Bohnet J, Haller E. Adjusted subcutaneous heparin versus heparin plus dihydroergotamine in prevention of deep vein thrombosis after total hip arthroplasty. J Arthroplasty 1988; 3: 81-86
    CrossrefPubMedGoogle Scholar
  • 30 Freick H, Haas S. Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement. Thromb Res 1991; 63: 133-143
    CrossrefPubMedGoogle Scholar
  • 31 Bergqvist D, Efsing HO, Hallbook T, Lindblad B. Prevention of postoperative thromboembolic complications. Acta Chir Scand 1980; 146: 559-568
    PubMedGoogle Scholar
  • 32 Haas S, Stemberger A, Fritsche H-M, Lechner F. Untersuchungen zur antithrombotischen Wirksamkeit von niedermolekularem Heparin Kabi. Med Welt 1987; 38: 714-720
    PubMedGoogle Scholar
  • 33 Haas S, Stemberger A, Fritsche H-M, Welzel D, Wolf H, Lechner F, Blumel G. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine. Arzneim-Forsch/Drug Res 1987; 37: 839-843
    PubMedGoogle Scholar
  • 34 Josefsson G, Dahlqvist A, Bodfors B. Prevention of thromboembolism in total hip replacement. Aspirin versus dihydroergotamine-heparin. Acta Orthop Scand 1987; 58: 626-629
    PubMedGoogle Scholar
  • 35 Moskovitz PA, Ellenberg SS, Feffer HL, Kenmore PI, Neviaser RJ, Rubin BC, Varma VM. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Jt Surg 1978; 60-A: 1065-1070
    PubMedGoogle Scholar
  • 36 Rogers PH, Walsh PN, Marder VJ, Bosak GC, Lachman JW, Ritchie WGM, Oppenheimer L, Sherry S. Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip. J Bone Jt Surg 1978; 60-A: 758-762
    PubMedGoogle Scholar
  • 37 Hume M, Kuriakose TX, Zuch L, Turner RH. 125I-fibrinogen and the prevention of venous thrombosis. Arch Surg 1973; 107: 803-806
    CrossrefPubMedGoogle Scholar
  • 38 Hampson WGJ, Harris FC, Lucas HK, Roberts PH, McCall IW, Jackson PC, Powell NL, Staddon GE. Failure of low dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty. Lancet 1974; 2: 795-797
    PubMedGoogle Scholar
  • 39 Morris GK, Henry APJ, Preston BJ. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. The Lancet 1974; 2: 797-800
    PubMedGoogle Scholar
  • 40 Dechavanne M, Saudin F, Viala J-J, Kher A, Bertrix L, de Mourgues G. Prevention des thromboses veineuses. Succès de l’héparine à fortes doses lors des coxarthroses. Nouv Presse Méd 1974; 3: 1317-1319
    PubMedGoogle Scholar
  • 41 Dechavanne M, Ville D, Viala JJ, Kher A, Faivre J, Pousset MB, Dejour H. Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in the prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis 1975; 4: 094-100
    PubMedGoogle Scholar
  • 42 Venous Thrombosis Study Group Small doses of subcutaneous sodium heparin in the prevention of deep vein thrombosis after elective hip operations. Br J Surg 1975 62. 348-350
    PubMedGoogle Scholar
  • 43 Mannucci PM, Citterio LE, Panajotopoulos N. Low-dose heparin and deep-vein thrombosis after total hip replacement. Thromb Haemostas 1976; 36: 157-164
    PubMedGoogle Scholar
  • 44 Schondorf TH. Thromboembolieprophylaxe mit Heparin bei elektiven Hüftgelenksoperationen. Dtsch Med Wochenschr 1978; 103: 1877-1881
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Bergqvist D, Efsing HO, Hallbook T, Hedlund T. Thromboembolism after elective and post-traumatic hip surgery – a controlled prophylactic trial with dextran 70 and low-dose heparin. Acta Chir Scand 1979; 145: 213-218
    PubMedGoogle Scholar
  • 46 Harris WH, Salzman EW, Athanasoulis C, Waltman AC, Baum S, DeSanctis R. Comparison of warfarin, low-molecular-weight dextran, aspirin and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Jt Surg 1974; 56-A: 1552-1562
    PubMedGoogle Scholar
  • 47 Leyvraz PF, Richard J, Bachmann F, van Melle G, Treyvaud J-M, Livio J-J, Candarjis G. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 1983; 309: 954-958
    CrossrefPubMedGoogle Scholar
  • 48 Planes A, Vochelle N, Fagola M, Bellaud M, Feret J, Salzard C, Planes M. Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep-vein thrombosis after total hip replacement. Acta Chir Scand 1990; Suppl 556: 108-115
    PubMedGoogle Scholar
  • 49 Eriksson BI, Kalebo P, Anthmyr BA, Wadenvik H, Tengborn L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. J Bone Jt Surg 1991; 73-A: 484-493
    PubMedGoogle Scholar
  • 50 Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991; 114: 545-551
    PubMedGoogle Scholar
  • 51 Barber HM, Feil EJ, Galasko CSB, Edwards DH, Sutton RA, Haynes DW, Bentley G. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement. Postgrad Med J 1977; 53: 130-133
    CrossrefPubMedGoogle Scholar
  • 52 Taberner DA, Poller L, Thomson JM, Lemon G, Weighill FJ. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg 1989; 76: 933-935
    CrossrefPubMedGoogle Scholar
  • 53 Easterbrook P, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 1: 867-872
    PubMedGoogle Scholar
  • 54 Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers T. Metaanalysis of randomized controlled trials. N Engl J Med 1987; 316: 450-455
    CrossrefPubMedGoogle Scholar
  • 55 Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by preoperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162-1173
    PubMedGoogle Scholar
  • 56 Kakkar VV, Fok PJ, Murray WJG, Paes T, Merenstein D, Doodds R, Farrell R, Crellin RQ, Thomas EM, Morley TR, Price AJ. Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty. J Bone Jt Surg 1985; 67-B: 538-542
    CrossrefPubMedGoogle Scholar